Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Clavis Pharma

Home Clinical Trial Sponsors and OrganizationsClavis Pharma

Clavis Pharma

ACTIVE

Norwayonline-rezeptfrei.net/prednisolon-tablettenPrivate11–50 employeesEstablished: 2001-01-01

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

18

7 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2001

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

7

38.9%

Phase 2

5

27.8%

Phase 3

1

5.6%

Trial Status Distribution

Active, not recruiting

7

38.9%

Completed

11

61.1%

Clinical Trials

Trials sponsored by this organization (18)

Elacytarabine Mass Balance Study in Healthy Volunteers

Feb 20136 participants

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia

Active, not recruiting

Oct 2010380 participants

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia

Active, not recruiting

Oct 2010380 participants

The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055)

Oct 201043 participants

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia

Active, not recruiting

Jun 2010380 participants

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Jun 2010381 participants

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia

Active, not recruiting

May 2010380 participants

A Randomised Phase III Study of Elacytarabine vs. Investigator´s Choice in Patientswith Late Stage Acute Myeloid LeukaemiaEstudio aleatorizado fase III de elacitarabina comparada con la elección del investigador en pacientes con leucemia mieloide aguda en estadio avanzado

Active, not recruiting

May 2010350 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials18
Approvals
News

Back to Organizations